These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34929104)

  • 21. Structural brain network measures are superior to vascular burden scores in predicting early cognitive impairment in post stroke patients with small vessel disease.
    Du J; Wang Y; Zhi N; Geng J; Cao W; Yu L; Mi J; Zhou Y; Xu Q; Wen W; Sachdev P
    Neuroimage Clin; 2019; 22():101712. PubMed ID: 30772684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural network efficiency is associated with cognitive impairment in small-vessel disease.
    Lawrence AJ; Chung AW; Morris RG; Markus HS; Barrick TR
    Neurology; 2014 Jul; 83(4):304-11. PubMed ID: 24951477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of rich club organisation in cerebral small vessel disease.
    Tuladhar AM; Lawrence A; Norris DG; Barrick TR; Markus HS; de Leeuw FE
    Hum Brain Mapp; 2017 Apr; 38(4):1751-1766. PubMed ID: 27935154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion magnetic resonance imaging in cerebral small vessel disease.
    Lyoubi-Idrissi AL; Jouvent E; Poupon C; Chabriat H
    Rev Neurol (Paris); 2017 Apr; 173(4):201-210. PubMed ID: 28392060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of thresholding on the consistency and sensitivity of diffusion MRI-based brain networks in patients with cerebral small vessel disease.
    De Brito Robalo BM; Vlegels N; Leemans A; Reijmer YD; Biessels GJ
    Brain Behav; 2022 May; 12(5):e2523. PubMed ID: 35413156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study.
    van Norden AG; de Laat KF; van Dijk EJ; van Uden IW; van Oudheusden LJ; Gons RA; Norris DG; Zwiers MP; de Leeuw FE
    Biochim Biophys Acta; 2012 Mar; 1822(3):401-7. PubMed ID: 21549191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Relation Between Structural Network Efficiency, Cognition, and Gait in Cerebral Small Vessel Disease.
    Cai M; Jacob MA; Norris DG; de Leeuw FE; Tuladhar AM
    J Gerontol A Biol Sci Med Sci; 2022 Mar; 77(3):554-560. PubMed ID: 34459914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal decline in structural networks predicts dementia in cerebral small vessel disease.
    Lawrence AJ; Zeestraten EA; Benjamin P; Lambert CP; Morris RG; Barrick TR; Markus HS
    Neurology; 2018 May; 90(21):e1898-e1910. PubMed ID: 29695593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognition mediates the relation between structural network efficiency and gait in small vessel disease.
    Cai M; Jacob MA; Norris DG; Duering M; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2021; 30():102667. PubMed ID: 33887698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study.
    Lawrence AJ; Patel B; Morris RG; MacKinnon AD; Rich PM; Barrick TR; Markus HS
    PLoS One; 2013; 8(4):e61014. PubMed ID: 23613774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies.
    Croall ID; Lohner V; Moynihan B; Khan U; Hassan A; O'Brien JT; Morris RG; Tozer DJ; Cambridge VC; Harkness K; Werring DJ; Blamire AM; Ford GA; Barrick TR; Markus HS
    Clin Sci (Lond); 2017 Jun; 131(12):1361-1373. PubMed ID: 28487471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free water determines diffusion alterations and clinical status in cerebral small vessel disease.
    Duering M; Finsterwalder S; Baykara E; Tuladhar AM; Gesierich B; Konieczny MJ; Malik R; Franzmeier N; Ewers M; Jouvent E; Biessels GJ; Schmidt R; de Leeuw FE; Pasternak O; Dichgans M
    Alzheimers Dement; 2018 Jun; 14(6):764-774. PubMed ID: 29406155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodal tract-based MRI metrics outperform whole brain markers in determining cognitive impact of small vessel disease-related brain injury.
    De Luca A; Kuijf H; Exalto L; Thiebaut de Schotten M; Biessels GJ;
    Brain Struct Funct; 2022 Sep; 227(7):2553-2567. PubMed ID: 35994115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive function in small vessel disease: the additional value of diffusion tensor imaging to conventional magnetic resonance imaging: the RUN DMC study.
    van Norden AG; van Uden IW; de Laat KF; van Dijk EJ; de Leeuw FE
    J Alzheimers Dis; 2012; 32(3):667-76. PubMed ID: 22850313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of the total small vessel disease burden on the structural brain network.
    Xu X; Lau KK; Wong YK; Mak HKF; Hui ES
    Sci Rep; 2018 May; 8(1):7442. PubMed ID: 29748646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of white matter at the centrum semiovale level with magnetic resonance spectroscopy and diffusion tensor imaging in cerebral small vessel disease.
    Huang LA; Ling XY; Li C; Zhang SJ; Chi GB; Xu AD
    Genet Mol Res; 2014 Apr; 13(2):2683-90. PubMed ID: 24782057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation.
    Charidimou A; Martinez-Ramirez S; Reijmer YD; Oliveira-Filho J; Lauer A; Roongpiboonsopit D; Frosch M; Vashkevich A; Ayres A; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
    JAMA Neurol; 2016 Aug; 73(8):994-1001. PubMed ID: 27366898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Test-retest reliability and sample size estimates after MRI scanner relocation.
    Melzer TR; Keenan RJ; Leeper GJ; Kingston-Smith S; Felton SA; Green SK; Henderson KJ; Palmer NJ; Shoorangiz R; Almuqbel MM; Myall DJ
    Neuroimage; 2020 May; 211():116608. PubMed ID: 32032737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of amyloid and small vessel disease on white matter network disruption.
    Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials.
    Benjamin P; Zeestraten E; Lambert C; Ster IC; Williams OA; Lawrence AJ; Patel B; MacKinnon AD; Barrick TR; Markus HS
    J Cereb Blood Flow Metab; 2016 Jan; 36(1):228-40. PubMed ID: 26036939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.